Replies to post #221460 on Biotech Values

[jb_118]

ARWR R&D Day slides (2019):

http://ir.arrowheadpharma.com/static-files/26bc6a27-874e-4524-87e2-2134b56d00e4


Link to webcast (3+ hours)
http://lifesci.rampard.com/20191018/reg.jsp

I haven't gone over the whole thing, but the HBV work isn't mentioned much in the slide deck. They will have late breakers on both APOC3 and ANG3 and AHA November 18th.

Amgen seems to have dropped one of their collaborations on an undisclosed CV target.